JP2003221386A - 二環性誘導体、その製造法およびその用途 - Google Patents

二環性誘導体、その製造法およびその用途

Info

Publication number
JP2003221386A
JP2003221386A JP2002341477A JP2002341477A JP2003221386A JP 2003221386 A JP2003221386 A JP 2003221386A JP 2002341477 A JP2002341477 A JP 2002341477A JP 2002341477 A JP2002341477 A JP 2002341477A JP 2003221386 A JP2003221386 A JP 2003221386A
Authority
JP
Japan
Prior art keywords
group
optionally substituted
purity
retention time
apci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2002341477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003221386A5 (enrdf_load_stackoverflow
Inventor
Tsuneo Oda
恒夫 小田
Michi Imada
岐 今田
Kenichiro Naito
健一郎 内藤
Hisaya Tamura
寿哉 田村
Shuichi Furuya
修一 古矢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP2002341477A priority Critical patent/JP2003221386A/ja
Publication of JP2003221386A publication Critical patent/JP2003221386A/ja
Publication of JP2003221386A5 publication Critical patent/JP2003221386A5/ja
Ceased legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2002341477A 2001-11-26 2002-11-25 二環性誘導体、その製造法およびその用途 Ceased JP2003221386A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002341477A JP2003221386A (ja) 2001-11-26 2002-11-25 二環性誘導体、その製造法およびその用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001359753 2001-11-26
JP2001-359753 2001-11-26
JP2002341477A JP2003221386A (ja) 2001-11-26 2002-11-25 二環性誘導体、その製造法およびその用途

Publications (2)

Publication Number Publication Date
JP2003221386A true JP2003221386A (ja) 2003-08-05
JP2003221386A5 JP2003221386A5 (enrdf_load_stackoverflow) 2005-09-08

Family

ID=27759288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002341477A Ceased JP2003221386A (ja) 2001-11-26 2002-11-25 二環性誘導体、その製造法およびその用途

Country Status (1)

Country Link
JP (1) JP2003221386A (enrdf_load_stackoverflow)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008528578A (ja) * 2005-01-28 2008-07-31 ダエウン ファーマシューティカル カンパニー リミテッド 新規のベンゾイミダゾール誘導体及びこれを含む薬剤学的組成物
US8436012B2 (en) 2008-08-05 2013-05-07 Daiichi Sankyo Company, Limited Imidazopyridin-2-one derivatives
JP2014502988A (ja) * 2011-01-21 2014-02-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン
JP2014101359A (ja) * 2012-10-26 2014-06-05 Mie Univ がん細胞阻害薬、がん幹細胞検出用プローブ
JP2014143413A (ja) * 2012-12-28 2014-08-07 Dow Global Technologies Llc 電子薄膜および電子デバイスのためのキノリン−ベンゾオキサゾール由来化合物
JP2015044854A (ja) * 2007-12-07 2015-03-12 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated シクロアルキルカルボキサミドピリジン安息香酸を生成するためのプロセス
JP2015096550A (ja) * 2011-02-25 2015-05-21 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 抗糖尿病剤として有用な新規環状アザベンゾイミダゾール誘導体
JP2015193639A (ja) * 2005-03-25 2015-11-05 サーフェイス ロジックス,インコーポレイティド 薬物動態的改良型化合物
JP2016539979A (ja) * 2013-12-09 2016-12-22 ユーシービー バイオファルマ エスピーアールエル Tnf活性のモジュレーターとしてのイミダゾピリジン誘導体
US9725440B2 (en) 2007-05-09 2017-08-08 Vertex Pharmaceuticals Incorporated Modulators of CFTR
US9751890B2 (en) 2008-02-28 2017-09-05 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as CFTR modulators
US9840499B2 (en) 2007-12-07 2017-12-12 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
US10076513B2 (en) 2010-04-07 2018-09-18 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
US10231932B2 (en) 2013-11-12 2019-03-19 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
US10302602B2 (en) 2014-11-18 2019-05-28 Vertex Pharmaceuticals Incorporated Process of conducting high throughput testing high performance liquid chromatography
US10626111B2 (en) 2004-01-30 2020-04-21 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
CN116903554A (zh) * 2023-09-13 2023-10-20 北京科翔中升医药科技有限公司 Vista和pd-1/pd-l1双靶点小分子抑制剂及其制备方法和用途

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10626111B2 (en) 2004-01-30 2020-04-21 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
JP2008528578A (ja) * 2005-01-28 2008-07-31 ダエウン ファーマシューティカル カンパニー リミテッド 新規のベンゾイミダゾール誘導体及びこれを含む薬剤学的組成物
JP2015193639A (ja) * 2005-03-25 2015-11-05 サーフェイス ロジックス,インコーポレイティド 薬物動態的改良型化合物
US11084804B2 (en) 2005-11-08 2021-08-10 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US9725440B2 (en) 2007-05-09 2017-08-08 Vertex Pharmaceuticals Incorporated Modulators of CFTR
US9776968B2 (en) 2007-12-07 2017-10-03 Vertex Pharmaceuticals Incorporated Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
US12065432B2 (en) 2007-12-07 2024-08-20 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
US10597384B2 (en) 2007-12-07 2020-03-24 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
US9840499B2 (en) 2007-12-07 2017-12-12 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
JP2015044854A (ja) * 2007-12-07 2015-03-12 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated シクロアルキルカルボキサミドピリジン安息香酸を生成するためのプロセス
US9751890B2 (en) 2008-02-28 2017-09-05 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as CFTR modulators
US8785438B2 (en) 2008-08-05 2014-07-22 Daiichi Sankyo Company, Limited Imidazopyridin-2-one derivatives
US8436012B2 (en) 2008-08-05 2013-05-07 Daiichi Sankyo Company, Limited Imidazopyridin-2-one derivatives
US10076513B2 (en) 2010-04-07 2018-09-18 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
US11052075B2 (en) 2010-04-07 2021-07-06 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
JP2014502988A (ja) * 2011-01-21 2014-02-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病、肥満および関連障害の治療のためのgpr119モジュレーターとしての縮合ジヒドロフラン
JP2015096550A (ja) * 2011-02-25 2015-05-21 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 抗糖尿病剤として有用な新規環状アザベンゾイミダゾール誘導体
JP2014101359A (ja) * 2012-10-26 2014-06-05 Mie Univ がん細胞阻害薬、がん幹細胞検出用プローブ
US10220024B2 (en) 2012-10-26 2019-03-05 Canon Kabushiki Kaisha Method of inhibiting cancer cell, method for detecting cancer cell, and system for detecting cancer cell
JP2014143413A (ja) * 2012-12-28 2014-08-07 Dow Global Technologies Llc 電子薄膜および電子デバイスのためのキノリン−ベンゾオキサゾール由来化合物
US10231932B2 (en) 2013-11-12 2019-03-19 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
JP2016539979A (ja) * 2013-12-09 2016-12-22 ユーシービー バイオファルマ エスピーアールエル Tnf活性のモジュレーターとしてのイミダゾピリジン誘導体
US10302602B2 (en) 2014-11-18 2019-05-28 Vertex Pharmaceuticals Incorporated Process of conducting high throughput testing high performance liquid chromatography
CN116903554A (zh) * 2023-09-13 2023-10-20 北京科翔中升医药科技有限公司 Vista和pd-1/pd-l1双靶点小分子抑制剂及其制备方法和用途

Similar Documents

Publication Publication Date Title
US7622479B2 (en) Bicyclic derivative, its production and use
KR102593742B1 (ko) 인다졸-3-카복사마이드를 사용하는 방법 및 wnt/b-카테닌 신호전달 경로 억제제로서의 그들의 용도
JP2003221386A (ja) 二環性誘導体、その製造法およびその用途
TWI699359B (zh) 4h-吡咯[3,2-c]吡啶-4-酮衍生物
JP6378409B2 (ja) 1H−ピラゾロ[3,4−b]ピリジンおよびそれらの治療的使用
ES2708211T3 (es) 3-amino-1,5,6,7-tetrahidro-4H-indol-4-onas
JP6401345B2 (ja) Wntシグナル伝達経路のインダゾール阻害剤およびそれらの治療的使用
JP6355648B2 (ja) Wntシグナル伝達経路の3−(ベンゾイミダゾール−2−イル)−インダゾール阻害剤およびそれらの治療的使用
JP6181862B2 (ja) ピラゾロピロリジン誘導体および疾患の処置におけるその使用
JP6290203B2 (ja) ヘッジホッグ経路阻害剤としてのn−(3−ヘテロアリールアリール)−4−アリールアリールカルボキサミド及び類似体並びにそれらの使用
US20110052562A1 (en) Benzimidazoles and analogs as rho kinase inhibitors
US20070010537A1 (en) Fused pyramidine derivative and use thereof
IL302807A (en) Gcn2 and perk kinase inhibitors and methods of use thereof
US20040072876A1 (en) Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
WO2004060362A2 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
KR20050098286A (ko) 사이클릭 우레아 유도체, 이의 제조방법 및 키나제억제제로서의 이의 약제학적 용도
CN104817497B (zh) 一种炔代喹啉衍生物及其制备方法和用途
EP3587406A1 (en) 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer
EP0927166A1 (en) Amides as npy5 receptor antagonists
EA029892B1 (ru) Азотсодержащее гетероциклическое соединение
JP2003321472A (ja) Grk阻害剤
WO2008109613A1 (en) Benzo[c][2,7]naphthyridine derivatives, and their use as kinase inhibitors
WO2005019188A1 (ja) 縮合ピリミジン誘導体およびその用途
JP2000143635A (ja) 血管新生阻害剤
JP4921168B2 (ja) ベンジルベンズイミダゾリル誘導体

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050311

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090107

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20090107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090217

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090408

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090630

A045 Written measure of dismissal of application

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20091027